Attention nasdaq: regn investors: contact berger montague about a regeneron pharmaceuticals, inc. class action lawsuit

Philadelphia , jan. 13, 2025 /prnewswire/ -- a securities class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn).

REGN Ratings Summary

REGN Quant Ranking